Volume 46, Issue 12 e14449
ORIGINAL ARTICLE

Exploring the potential of Lacticaseibacillus paracasei M11 on antidiabetic, anti-inflammatory, and ACE inhibitory effects of fermented dromedary camel milk (Camelus dromedaries) and the release of antidiabetic and anti-hypertensive peptides

Pratik Shukla

Pratik Shukla

Dairy Microbiology Department, SMC College of Dairy Science, Anand, Gujarat, India

Search for more papers by this author
Amar Sakure

Amar Sakure

Department of Plant Biotechnology, B.A College of Agriculture, Anand, Gujarat, India

Search for more papers by this author
Rinkal Pipaliya

Rinkal Pipaliya

Dairy Microbiology Department, SMC College of Dairy Science, Anand, Gujarat, India

Search for more papers by this author
Bethsheba Basaiawmoit

Bethsheba Basaiawmoit

Department of Rural Development and Agricultural Production, North-Eastern Hill University, Chasingre, Meghalaya, India

Search for more papers by this author
Ruchika Maurya

Ruchika Maurya

Healthy Gut Research Group, Food & Nutritional Biotechnology Division, Centre of Excellence in Functional Foods, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab, India

Search for more papers by this author
Mahendra Bishnoi

Mahendra Bishnoi

Healthy Gut Research Group, Food & Nutritional Biotechnology Division, Centre of Excellence in Functional Foods, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab, India

Search for more papers by this author
Kanthi Kiran Kondepudi

Kanthi Kiran Kondepudi

Healthy Gut Research Group, Food & Nutritional Biotechnology Division, Centre of Excellence in Functional Foods, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab, India

Search for more papers by this author
Subrota Hati

Corresponding Author

Subrota Hati

Dairy Microbiology Department, SMC College of Dairy Science, Anand, Gujarat, India

Correspondence

Subrota Hati, Department of Dairy Microbiology, Anand Agricultural University, Anand 388110, Gujarat, India.

Email: [email protected]

Search for more papers by this author
First published: 07 October 2022
Citations: 17

Abstract

The goal of this investigation was to find antidiabetic peptides and inhibit angiotensin converting enzyme (ACE) in Lacticaseibacillus paracasei (M11) fermented dromedary camel milk (Camelus dromedaries). According to the findings, the rate of antidiabetic activity increased along with the incubation periods and reached its peak after 48 hr of fermentation. The inhibitions of α-amylase, α-glucosidase, and lipase were 80.75, 59.62, and 65.46%, respectively. The inhibitory activity of ACE was 78.33%, and the proteolytic activity was 8.90 mg/mL. M11 at 0.25 mg/mL effectively suppressed LPS-induced pro-inflammatory cytokines and their mediators such as NO, TNF-α, IL-6, and IL-1β in RAW 264.7 cells. The rate of inoculum in the optimization phase was 1.5–2.5%, and the greatest proteolytic activity was observed after 48 hr of fermentation. The investigation of the above property in the ultrafiltered fermented milk exhibited the highest antidiabetic and ACE inhibition activities in the 3 kDa than 10 kDa fractions. The molecular weight was determined employing SDS-PAGE, and the six-peptide sequences were identified using 2D gel electrophoresis. Due to its high proteolytic activity, the L. paracasei strain has been reported to be useful in the production of ACE-inhibitory and antidiabetic peptides. Amino acid sequences such from ɑ1, ɑ2, and β-caseins have been identified within fermented camel milk by searching on online databases, including BIOPEP (for antidiabetic peptides) and AHTPDB (for hypertension peptides) to validate the antidiabetic and ACE-inhibitory actions of several peptides.

Practical applications

The study aims to identify antidiabetic peptides and inhibit ACE in dromedary camel milk fermented with Lacticaseibacillus paracasei M11. Maximum antidiabetic and ACE-inhibitory actions of the fermented camel milk were observed in 3 kDa permeate fractions. Fermented camel milk significantly reduced the excessive TNF-α, IL-6, and IL-1β production in LPS-activated RAW 264.7 cells. RP-LC/MS was used to identify 6 bioactive peptides from dromedary fermented camel milk. This fermented camel milk could be used for the management of hypertension and diabetic related problems.

CONFLICT OF INTEREST

The authors have declared no conflicts of interest for this article.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.